Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Research Partnership

Website
Email
+44 (0)20 8069 5000

Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science companies that optimizes commercialization success through evidence-based, story-told insights and recommendations. We provide custom market insights, syndicated real-world insights, and market access insights for the entire product lifecycle. Derived through rigorous research design and socialized outputs and delivered through an agile, collaborative approach by market research experts and thought leaders, our insights empower better decisions and create long-term value for patients.

We are the intelligence powering healthcare.

Chester House, Fulham Green, 81-83 Fulham High Street, London, SW6 3JW, United Kingdom

Using the full range of qualitative and quantitative techniques, we specialise in custom research and consultancy.

Prescription medicines
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.

Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients and consumers to deliver integrated insights.

Medical devices and diagnostics
Our experience covers everything from insulin pens to large-scale surgical systems. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.

From market understanding, forecasting and landscaping, through ideation, concept testing, product and brand development, profiling, communications testing, launch and tracking, we support pharma through the lifecycle of the brand.

Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Research Partnership makes two senior appointments to bolster its US and MedTech operations

Research Partnership is delighted to announce the appointments of Sue Wild as President, US Pharma in the US and Tom Donnelly as a Director in the US MedTech division.

Research Partnership appoints new CEO

Research Partnership has appointed Gareth Phillips to take over as CEO

MedTech specialist joins Research Partnership

Janet Powers has joined the company as a Director in the MedTech division.

Research Partnership is on the rise

Research Partnership ranks 12th in fastest growing UK market research agency league  tables

Research Partnership’s MedTech Division appoints two Directors

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

ALL PRESS RELEASES

Pharmaceutical Market Research Conference 2016

Research Partnership exhibited and presented a paper at the Pharmaceutical Market Research Conference last week in Parsippany, NJ.Representing Research Partnership were US President Harriet Kozak and Director Phil Rosenberg.Harriet presented the paper...

Nicole Bender Moreira promoted to Associate Director, Singapore office

Research Partnership is delighted to announce the promotion of Nicole Bender Moreira to Associate Director in recognition of the contribution she has made to the growing success of our Singapore...

New appointments announced across Research Partnership’s global offices

We are delighted to welcome Marianne Jaeger as Associate Director to our London headquarters

What to Consider When Conducting Patient Research in Saudi Arabia

The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.

Research Partnership hires Graphic Designer to create storytelling deliverables

Research Partnership has extended its healthcare research and consulting offering to include storytelling deliverables with the hire of multi-media graphic designer Amanda Brent at the company’s London headquarters. Working with...

Research Partnership is UK’s fastest growing healthcare market research specialist

The latest league tables for the UK market research industry have just been released and reveal Research Partnership to be the fastest growing healthcare market research specialist for 2014.With turnover...

Emerging Markets: Your Essential Guide

Using our combined knowledge and years of experience of working in these territories, our experts have produced an essential guide to help address some of the core challenges for conducting market...

Free Thinking: From promise to practice: immuno-oncology in action

This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that...

Exploring the Opportunity For Halal In Healthcare

Published in Medical Marketing & Media November 2015

Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets

Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets

ALL WHITE PAPERS

Gareth Phillips

Gareth Phillips
CEO
gareth.phillips@researchpartnership.com

Sue Wild

Sue Wild
US President
sue.wild@researchpartnership.com

Marc Yates

Marc Yates
Senior Director, Emerging Markets
marc.yates@researchpartnership.com

Angela Duffy

Angela Duffy
EU Managing Director
angela.duffy@researchpartnership.com

https://www.researchpartnership.com/about/client-satisfaction-and-reviews

“The team did an excellent job designing, executing, and synthesizing the data & insights from this study. It was a challenging project involving a large number of countries and in the end the team put together very thorough reports and a concise summary. The input during the design of the quant survey was also very valuable and ensured the right type of data was collected.”
Director, Commercial Planning & Operations

“I just want to thank you for the recent project you ran very successfully. The report delivered was high quality, definitely bringing new insights and ways to look at our marketing issue. It was also clear at the presentation that you had a deep understanding of the disease area. Very good job
Director, Business Analysis

“Your results have driven key decision making which is now translating into very good performance for our brand, so well done.”
Commercial Analysis Manager

“I would like to thank all of you for the excellent work you did and all the support provided. Your expertise and professionalism was highly appreciated, as were the provided results. I’m already looking forward to the next possibility to work with you”
International Business Analyst

“I just wanted to tell you how impressed I continue to be with the team at Research Partnership. They never seem to tire, take copious notes and remain engaged each and every day. It has certainly been a pleasure working with the team and I look forward to a continued partnership!”
Associate Director, Global Marketing Science

Please note – you must be logged in to X in this browser in order to see this Twitter / X Feed

Company Details

- PMLiVE

Email
Website

 Latest Content from  Research Partnership 

Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...

Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot

This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across...

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

Authored by: Ellie Forde and Mark Braund, Directors

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI

Authored by Paul Reed and Anabelle Gall

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...